<DOC>
	<DOCNO>NCT02505113</DOCNO>
	<brief_summary>To observe etiology , diagnosis , management prognosis cavernous transformation portal vein .</brief_summary>
	<brief_title>Cavernous Transformation Portal Veinï¼š Etiology , Diagnosis , Management Prognosis</brief_title>
	<detailed_description>To observe etiology , diagnosis , management prognosis cavernous transformation portal vein . We perform Montelukast ( 10mg , q.d. , p.o . ) fot treatment symptomatic cavernous transformation portal vein observe efficacy decrease volume ascites hydrothorax .</detailed_description>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>All patient CTPV . Patients know severe dysfunction heart , lung , brain , kidney vital organ .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Portal Vein , Cavernous Transformation Of</keyword>
	<keyword>Hypertension , Portal</keyword>
</DOC>